Wybiologics Appoints Yoon Joo-han as New Head of Research Institute

Y-Biologics announced on the 11th that it has appointed Dr. Yoon Joo-han, an immunology Ph.D., as the new head of its research institute. This move aims to strengthen new drug development capabilities and accelerate early technology transfer.

Yoon Juhan, New Head of Research at Y-Biologics
[Photo by Y-Biologics]

Dr. Yoon Joo-han, the newly appointed head of the research institute, graduated from the College of Life Sciences at Korea University and earned his Ph.D. in Immunology from the Mayo Clinic in the United States. He has since held positions such as postdoctoral researcher at Harvard Medical School’s Children’s Hospital, senior researcher at JW Pharmaceutical, Chief Technology Officer (CTO) at Virocure, CTO at MirimGen, and Chief Strategy Officer (CSO) at Emuse Therapeutics, gaining extensive experience and expertise in developing various new drugs, including immuno-oncology agents.

Dr. Yoon is expected to lead efforts to strengthen immuno-oncology drug development capabilities and discover new candidate substances at Y-Biologics. Based on its antibody discovery platform technology, Y-Biologics is developing biopharmaceuticals across various modalities (therapeutic approaches). Since antibodies are a core element of advanced biopharmaceuticals, they can be applied in diverse fields such as antibody-drug conjugates (ADC), immuno-oncology agents, bispecific antibodies, and cell and gene therapies.

Dr. Yoon will also lead the technology transfer of new drug candidates. Given his experience in licensing a new drug candidate for atopic dermatitis during the preclinical stage, he plans to leverage this expertise.

Park Beom-chan, Senior Vice President of Y-Biologics, said, “We expect Dr. Yoon’s immunology-based new drug development experience to create synergy with Y-Biologics’ antibody discovery platform,” adding, “This will enable us to advance new drug research and development with global competitiveness.”

This content was produced with the assistance of AI translation services.